Nicox to co-promote eye drug with Bausch + Lomb in the US
August 08, 2014 at 01:46 AM EDT
PARIS, Aug 8 (Reuters) - French pharmaceutical firm Nicox said it had notified Bausch + Lomb, a division of Valeant Pharmaceuticals, that it would exercise its option to co-promote eye drug latanoprostene bunod in the United States.
